Natural Extract Composition for Immune Disease Treatment

The patent changes the chemical composition parameters by using natural plant extracts instead of synthetic pharmaceutical compounds. The composition includes extracts from kaladana, cassia seeds, spurge, spikenard, wrinkled giant hyssop, Phytolaccaceae roots, Castanea crenata skin, white pharbitis seeds, Rosa multiflora fruits, and rhubarb, each containing specific bioactive compounds that modulate immune responses through natural mechanisms rather than forced pharmacological suppression.

The patent employs a composite formulation combining multiple natural plant extracts with different immunomodulatory properties. This composite approach allows the composition to address multiple aspects of allergic responses simultaneously - suppressing Th2 cytokines, inhibiting mast cell degranulation, and promoting Treg cell differentiation - while the natural origin of each component ensures safety and lack of serious side effects.

The patent converts the concept of immunosuppression from a harmful side effect into a beneficial mechanism by naturally promoting Treg cell differentiation. Instead of forcing immune suppression through steroids that damage healthy tissues, the composition uses natural plant compounds to guide immune cells toward a regulatory phenotype, turning potential harm into therapeutic benefit.

The natural plant extracts act as intermediaries that mediate immune modulation through multiple pathways. Rather than directly suppressing immune responses like steroids, these compounds work through intermediate mechanisms - modulating cytokine production, influencing cell differentiation, and regulating inflammatory pathways - to achieve anti-allergic effects without the toxic side effects of conventional steroids.

The patent segments the complex allergic response into distinct pathways - Th1/Th2 cytokine balance, mast cell degranulation, and Treg cell differentiation - and addresses each segment with specific natural compounds from the plant extracts. This segmented approach ensures comprehensive coverage of allergic mechanisms while maintaining the safety profile of natural substances.

The natural plant extracts in the composition exhibit multi-functionality, simultaneously affecting multiple aspects of allergic responses. The same compounds that suppress Th2 cytokines also inhibit mast cell degranulation and promote Treg differentiation, providing broad-spectrum anti-allergic activity from natural substances with verified effectiveness across multiple therapeutic targets.